Literature DB >> 16465070

Validation of ultrasonography to evaluate murine orthotopic oral cavity tumors.

John C Pezold1, Kurt Zinn, Melissa A Talbert, Renee Desmond, Eben L Rosenthal.   

Abstract

BACKGROUND: The murine orthotopic oral cavity tumor model allows evaluation of tumor growth and invasion. Currently, serial measurements of tissue growth are difficult to obtain since invasive procedures or animal sacrifice is necessary to evaluate tumor size. High-resolution ultrasound was evaluated as a noninvasive method to monitor tumor size in vivo.
METHODS: Sixteen immunodeficient mice, age 9 weeks, were injected transcervically with a human squamous cell carcinoma cell line into the tongue, and tumor volume was assessed by high-frequency ultrasound at 11 days. The animals were subsequently sacrificed and the tumors processed for histology. Tumor size was then calculated by caliper measurement in two dimensions.
RESULTS: Tumor dimensions obtained using ultrasound were found to significantly correlate with the histologic measurements (Spearman coefficient 0.90, p < 0.0001). Tumor dimensions were on average larger using ultrasound versus histologic measurements, although this was not significantly different than zero (95% confidence interval -13.96 to 62.37 mm2).
CONCLUSIONS: High-resolution ultrasound accurately measures tumor volume in the murine orthotopic oral cavity tumor model without sacrifice. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2006        PMID: 16465070     DOI: 10.1159/000091324

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  7 in total

1.  High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes.

Authors:  Elyse L Walk; Sarah L McLaughlin; Scott A Weed
Journal:  J Vis Exp       Date:  2015-07-25       Impact factor: 1.355

2.  Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Hyunki Kim; Karri D Folks; Lingling Guo; Jeffery C Sellers; Naomi S Fineberg; Cecil R Stockard; William E Grizzle; Donald J Buchsbaum; Desiree E Morgan; James F George; Kurt R Zinn
Journal:  Mol Imaging       Date:  2011-06       Impact factor: 4.488

3.  Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.

Authors:  Hyunki Kim; Guihua Zhai; Zhiyong Liu; Sharon Samuel; Nemil Shah; Emily E Helman; Joseph A Knowles; Cecil R Stockard; Naomi S Fineberg; William E Grizzle; Tong Zhou; Kurt R Zinn; Eben L Rosenthal
Journal:  Anticancer Drugs       Date:  2011-10       Impact factor: 2.248

4.  Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.

Authors:  Leo Christopher DeRosier; Donald J Buchsbaum; Patsy G Oliver; Zhi-Qiang Huang; Jeffrey C Sellers; William E Grizzle; Wenquan Wang; Tong Zhou; Kurt R Zinn; Joshua W Long; Selwyn M Vickers
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

5.  Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.

Authors:  Hyunki Kim; Desiree E Morgan; Donald J Buchsbaum; Huadong Zeng; William E Grizzle; Jason M Warram; Cecil R Stockard; Lacey R McNally; Joshua W Long; Jeffrey C Sellers; Andres Forero; Kurt R Zinn
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

Review 6.  Ultrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging.

Authors:  A Greco; M Mancini; S Gargiulo; M Gramanzini; P P Claudio; A Brunetti; M Salvatore
Journal:  J Biomed Biotechnol       Date:  2011-10-25

7.  Use of high frequency ultrasound to monitor cervical lymph node alterations in mice.

Authors:  Elyse L Walk; Sarah McLaughlin; James Coad; Scott A Weed
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.